The global CAR T-cell therapy market is experiencing explosive growth, driven by rising demand for innovative cancer treatments. This therapy involves modifying a patient's own immune cells to target cancer cells, offering encouraging results in the treatment of diverse blood cancers. Leading factors driving market expansion include advancements in